Vincent Santora
17Patents
3h-index
36Co-inventors
60Inventor score
Filing activity: Feb 15, 2002 → Sep 21, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7196104B2 | Thiazolyl urea compounds and methods of uses | Chemistry; Metallurgy | 103 | Expired |
| US6645990B2 | Thiazolyl urea compounds and methods of uses | Chemistry; Metallurgy | 101 | Expired |
| US11912711B2 | Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of use | Chemistry; Metallurgy | 3 | Active |
| US11718617B2 | Heterocyclic compounds as triggering receptor expressed on myeloid cells2 agonists and methods of use | Chemistry; Metallurgy | 3 | Active |
| US11884675B2 | Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of use | Chemistry; Metallurgy | 3 | Active |
| US11608344B2 | Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of use | Chemistry; Metallurgy | 3 | Active |
| US9102674B2 | Substituted naphthyridine and quinoline compounds as MAO inhibitors | Chemistry; Metallurgy | 2 | Active |
| US9150572B2 | Substituted naphthyridine and quinoline compounds as MAO inhibitors | Chemistry; Metallurgy | 2 | Active |
| US9708334B2 | Substituted 2,4,5,6-tetrahydropyrrolo[3,4-c]pyrazole and 4,5,6,7-tetrahydro-2H-pyrazolo[4,3-c]pyridine compounds as GlyT1 inhibitors | Chemistry; Metallurgy | 2 | Active |
| US9675605B2 | Substituted naphthyridine and quinoline compounds as MAO inhibitors | Chemistry; Metallurgy | 1 | Active |
| US11685745B2 | Substituted benzoxazole and benzofuran compounds as PDE7 inhibitors | Chemistry; Metallurgy | 1 | Active |
| US12319691B2 | Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of use | Chemistry; Metallurgy | 0 | Active |
| US12428425B2 | Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of use | Chemistry; Metallurgy | 0 | Active |
| US9956213B2 | Substituted naphthyridine and quinoline compounds as MAO inhibitors | Chemistry; Metallurgy | 0 | Active |
| US10040759B2 | Substituted azetidinyl compounds as GlyT1 inhibitors | Chemistry; Metallurgy | 0 | Active |
| US12319702B2 | Substituted benzoxazole and benzofuran compounds as PDE7 inhibitors | Chemistry; Metallurgy | 0 | Active |
| US12252489B2 | Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of use | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.